[TENAGA] QoQ Annualized Quarter Result on 31-May-2007 [#3]

Announcement Date
13-Jul-2007
Admission Sponsor
-
Sponsor
-
Financial Year
31-Aug-2007
Quarter
31-May-2007 [#3]
Profit Trend
QoQ- -7.35%
YoY- 179.95%
Quarter Report
View:
Show?
Annualized Quarter Result
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Revenue 24,029,600 24,833,200 23,320,400 22,925,866 22,567,400 22,406,800 20,384,200 11.60%
PBT 5,721,600 6,576,000 4,765,900 5,915,200 5,977,400 5,350,400 2,756,800 62.78%
Tax -549,400 -508,400 -698,300 -678,133 -332,200 -359,200 -595,100 -5.19%
NP 5,172,200 6,067,600 4,067,600 5,237,066 5,645,200 4,991,200 2,161,700 78.98%
-
NP to SH 5,156,200 6,059,600 4,061,100 5,190,266 5,602,000 4,984,800 2,126,900 80.56%
-
Tax Rate 9.60% 7.73% 14.65% 11.46% 5.56% 6.71% 21.59% -
Total Cost 18,857,400 18,765,600 19,252,800 17,688,800 16,922,200 17,415,600 18,222,500 2.31%
-
Net Worth 26,166,567 25,558,792 23,702,585 23,865,908 22,822,961 21,341,906 19,033,567 23.66%
Dividend
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Div 866,442 - 1,553,075 1,136,471 846,863 - 599,354 27.87%
Div Payout % 16.80% - 38.24% 21.90% 15.12% - 28.18% -
Equity
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Net Worth 26,166,567 25,558,792 23,702,585 23,865,908 22,822,961 21,341,906 19,033,567 23.66%
NOSH 4,332,213 4,331,998 4,278,445 4,261,769 4,234,315 4,184,687 4,049,695 4.60%
Ratio Analysis
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
NP Margin 21.52% 24.43% 17.44% 22.84% 25.01% 22.28% 10.60% -
ROE 19.71% 23.71% 17.13% 21.75% 24.55% 23.36% 11.17% -
Per Share
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
RPS 554.67 573.25 545.07 537.94 532.96 535.45 503.35 6.69%
EPS 119.02 139.88 94.92 121.79 132.30 119.12 52.52 72.61%
DPS 20.00 0.00 36.30 26.67 20.00 0.00 14.80 22.25%
NAPS 6.04 5.90 5.54 5.60 5.39 5.10 4.70 18.22%
Adjusted Per Share Value based on latest NOSH - 4,316,725
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
RPS 414.52 428.39 402.29 395.48 389.30 386.53 351.64 11.60%
EPS 88.95 104.53 70.06 89.53 96.64 85.99 36.69 80.56%
DPS 14.95 0.00 26.79 19.60 14.61 0.00 10.34 27.89%
NAPS 4.5139 4.409 4.0888 4.117 3.9371 3.6816 3.2834 23.66%
Price Multiplier on Financial Quarter End Date
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Date 29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 -
Price 5.79 9.25 9.95 11.70 12.00 11.00 9.15 -
P/RPS 1.04 1.61 1.83 2.17 2.25 2.05 1.82 -31.16%
P/EPS 4.86 6.61 10.48 9.61 9.07 9.23 17.42 -57.33%
EY 20.56 15.12 9.54 10.41 11.03 10.83 5.74 134.28%
DY 3.45 0.00 3.65 2.28 1.67 0.00 1.62 65.60%
P/NAPS 0.96 1.57 1.80 2.09 2.23 2.16 1.95 -37.67%
Price Multiplier on Announcement Date
29/02/08 30/11/07 31/08/07 31/05/07 28/02/07 30/11/06 31/08/06 CAGR
Date 14/04/08 15/01/08 25/10/07 13/07/07 16/04/07 25/01/07 12/10/06 -
Price 4.48 6.37 9.45 11.60 12.20 12.20 9.85 -
P/RPS 0.81 1.11 1.73 2.16 2.29 2.28 1.96 -44.54%
P/EPS 3.76 4.55 9.96 9.52 9.22 10.24 18.75 -65.77%
EY 26.57 21.96 10.04 10.50 10.84 9.76 5.33 192.10%
DY 4.46 0.00 3.84 2.30 1.64 0.00 1.50 106.91%
P/NAPS 0.74 1.08 1.71 2.07 2.26 2.39 2.10 -50.14%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment